It was also determined that stimulation of CD4+ T cells provided protection against lethal infection by T. gondii. Vaccine formulations containing CD8+ T cell-stimulating epitopes, on the other hand, afforded protection to mice challenged upwards of 30 days after immunization. The gene discussed is CD4; the disease is infection.